OpenAI CEO Sam Altman is reportedly in active talks with the Trump administration about the US potentially acquiring a 5 percent stake in the leading AI firm.

Insider sources told the Financial Times that these talks are in “early stages,” but Altman “has argued that giving the public a financial stake in the company is the best way to share the upside of AI.”

Donald Trump favors the idea, and his administration has reportedly been talking to several AI firms about the possibility. According to FT’s sources, other companies approached to share similar stakes include Google and Meta.

Read full article

Comments

Near the end of May, the Office of Management and Budget (OMB) proposed a new rule that would govern how the federal government handles the grants it issues, including those that fund the vast majority of scientific research in the US.

If formalized, the rule would make political priorities the prime determinant of what science gets funded and sideline the opinions of scientific experts. Grants could be canceled due to political whims, and new layers of bureaucracy would inhibit basic scientific activities like publishing papers and attending conferences. Unlike the executive orders it echoes, it would have the force of law behind it and be significantly harder to challenge in court.

Before coming into force, however, the proposal must go through a process that includes public feedback and (potentially) changes in response. The deadline for that feedback—Monday, July 13—is rapidly approaching.

Read full article

Comments

The US has lifted export curbs on Anthropic’s newest Claude models, Fable 5 and Mythos 5, about three weeks after the Trump administration flagged the models as national security risks.

As of today, Anthropic confirmed in a blog post, Fable 5 will be available globally, and US organizations have had access restored to Mythos 5 since June 26. Anthropic said it is now working with the government to expand Mythos access to a “broader set of domestic and international partners in the Glasswing program.” That program allows cybersecurity researchers at trusted companies to access Mythos for defensive purposes.

In a letter to Anthropic viewed by Reuters and The New York Times, Commerce Secretary Howard Lutnick said Anthropic would “no longer need a license for exports or in-country transfers of its Claude Mythos and Claude Fable AI models.” The letter acknowledged that Anthropic had “taken steps in close coordination with the US government to address the risks” posed by the models.

Read full article

Comments

Another large study has found no link between autism and Tylenol use during pregnancy, refuting claims by President Trump and anti-vaccine Health Secretary Robert F. Kennedy Jr.

In September, Trump and Kennedy held a press conference in which they stated without clear evidence that the common fever and pain reducer acetaminophen—sold as Tylenol in the US and also known as paracetamol—causes autism in children if taken during pregnancy. Trump repeatedly warned pregnant people not to take Tylenol and instead "tough it out" with fever and/or pain.

Medical organizations decried Trump's message, emphasizing that acetaminophen is a safe pain and fever reliever during pregnancy and that untreated fever during pregnancy is known to increase the risk of autism in babies as well as other conditions, including miscarriage, birth defects, and premature birth. Still, the president's warning was effective. Texas sued the maker of Tylenol over the alleged connection. And a study in The Lancet in March found that use of acetaminophen in pregnant patients in emergency departments fell by 10 percent after Trump's press conference.

Read full article

Comments